Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.53B | $1.47B | $6.20B | $1.64B | $1.59B |
| Total Operating Revenue | $1.53B | $1.47B | $6.20B | $1.64B | $1.59B |
| Cost of Revenue | $836.10M | $787.90M | $3.43B | $890.40M | $871.20M |
| Gross Profit | $693.90M | $681.40M | $2.77B | $753.80M | $714.40M |
| Operating Expense | $417.50M | $390.40M | $1.70B | $487.80M | $459.80M |
| Selling and Admin Expenses | $417.50M | $390.40M | $1.70B | $487.80M | $459.80M |
| -Selling & Marketing Expense | $165.30M | $139.40M | $708.90M | $212.30M | $202.90M |
| -General & Admin Expense | $252.20M | $251.00M | $988.30M | $275.50M | $256.90M |
| Operating Profit | $276.40M | $291.00M | $1.08B | $266.00M | $254.60M |
| Net Non-Operating Interest Income (Expense) | -$22.80M | -$21.50M | -$71.70M | -$22.50M | -$20.90M |
| Non-Operating Interest Income | $1.40M | $2.50M | $23.50M | $2.10M | $2.90M |
| Non-Operating Interest Expense | $24.20M | $24.00M | $95.20M | $24.60M | $23.80M |
| Other Income (Expense) | $2.30M | $3.10M | -$49.00M | -$55.40M | $2.50M |
| Earnings from Equity Interest | $2.70M | $2.30M | $7.90M | $1.30M | $2.20M |
| Other Non-Operating Income (Expenses) | -$400,000.00 | $800,000.00 | -$56.90M | -$56.70M | $300,000.00 |
| Pretax Profit | $255.90M | $272.60M | $956.90M | $188.10M | $236.20M |
| Tax | $53.10M | $56.30M | $220.10M | $44.60M | $54.00M |
| Net Profit | $202.80M | $216.30M | $736.80M | $143.50M | $182.20M |
| Profit from Continuing Operations | $202.80M | $216.30M | $736.80M | $143.50M | $182.20M |
| Net Income to Parent Company | $202.80M | $216.30M | $736.80M | $143.50M | $182.20M |
| Net Income to Common Stockholders | $202.80M | $216.30M | $736.80M | $143.50M | $182.20M |
| Basic EPS | $0.86 | $0.91 | $3.04 | $0.60 | $0.75 |
| Diluted EPS | $0.85 | $0.91 | $3.02 | $0.60 | $0.75 |
| Dividend Per Share | $0.31 | $0.31 | $1.18 | $0.30 | $0.30 |
| Special Income (Charges) | – | – | $0.00 | $0.00 | $0.00 |
| -Less:Impairment of Capital Assets | – | – | $0.00 | $0.00 | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $9.11B | $9.01B | $8.91B | $8.91B | $9.14B |
| Total Current Assets | $1.52B | $1.72B | $1.60B | $1.60B | $1.63B |
| Cash and Cash Equivalents & Short-Term Investments | $254.80M | $503.40M | $409.00M | $409.00M | $305.30M |
| -Cash and Cash Equivalents | $254.80M | $503.40M | $409.00M | $409.00M | $305.30M |
| Receivables | $596.80M | $576.60M | $593.40M | $593.40M | $605.70M |
| -Accounts Receivable | $596.80M | $576.60M | $593.40M | $593.40M | $605.70M |
| Inventory | $601.90M | $578.40M | $534.80M | $534.80M | $647.40M |
| Other Current Assets | $68.20M | $62.30M | $59.80M | $59.80M | $72.40M |
| Total Non-Current Assets | $7.58B | $7.29B | $7.32B | $7.32B | $7.51B |
| Net PPE | $826.50M | $823.90M | $822.80M | $822.80M | $938.10M |
| -Gross PPE | $1.74B | $1.72B | $1.70B | $1.70B | $1.89B |
| -Accumulated Depreciation | -$912.90M | -$892.30M | -$874.20M | -$874.20M | -$956.80M |
| Investments and Advances | $12.10M | $12.30M | $10.30M | $10.30M | $10.90M |
| -Long Term Equity Investment | $12.10M | $12.30M | $10.30M | $10.30M | $10.90M |
| Goodwill and Other Intangible Assets | $6.39B | $6.11B | $6.14B | $6.14B | $6.19B |
| -Goodwill | $2.65B | $2.63B | $2.63B | $2.63B | $2.64B |
| -Other Intangible Assets | $3.74B | $3.48B | $3.51B | $3.51B | $3.55B |
| Other Non-Current Assets | $352.40M | $343.00M | $343.30M | $343.30M | $377.70M |
| Total Liabilities | $4.76B | $4.82B | $4.91B | $4.91B | $4.92B |
| Total Current Liabilities | $1.33B | $1.41B | $1.50B | $1.50B | $1.50B |
| Payables | $780.80M | $763.50M | $735.80M | $735.80M | $781.40M |
| -Accounts Payable | $775.90M | $729.90M | $732.40M | $732.40M | $772.70M |
| -Total Tax Payable | $4.90M | $33.60M | $3.40M | $3.40M | $8.70M |
| Current Accrued Expenses | $481.90M | $649.90M | $761.90M | $761.90M | $549.70M |
| Short-Term Debt and Capital Lease Obligation | $49.90M | – | – | – | – |
| -Current Debt | $49.90M | – | – | – | – |
| Other Current Liabilities | $14.60M | – | – | – | $170.00M |
| Total Non-Current Liabilities | $3.43B | $3.41B | $3.41B | $3.41B | $3.42B |
| Long Term Debt and Capital Lease Obligation | $2.21B | $2.21B | $2.21B | $2.21B | $2.20B |
| -Long Term Debt | $2.21B | $2.21B | $2.21B | $2.21B | $2.20B |
| Non-Current Deferred Liabilities | $894.10M | $891.60M | $886.90M | $886.90M | $884.20M |
| Other Non-Current Liabilities | $330.30M | $309.80M | $320.50M | $320.50M | $331.60M |
| Total Equity | $4.35B | $4.19B | $4.00B | $4.00B | $4.22B |
| Stockholders' Equity | $4.35B | $4.19B | $4.00B | $4.00B | $4.22B |
| Capital Stock | $293.70M | $293.70M | $293.70M | $293.70M | $293.70M |
| -Common Stock | $293.70M | $293.70M | $293.70M | $293.70M | $293.70M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $676.90M | $654.10M | $625.10M | $625.10M | $619.60M |
| Retained Earnings | $7.04B | $6.91B | $6.77B | $6.77B | $6.70B |
| Less: Treasury Stock | $3.65B | $3.66B | $3.66B | $3.66B | $3.37B |
| Gains/Losses Not Affecting Retained Earnings | -$14.50M | -$16.60M | -$19.90M | -$19.90M | -$20.00M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $286.80M | $174.80M | $1.22B | $363.40M | $435.50M |
| Net cash flow from continuing operations | $286.80M | $174.80M | $1.22B | $363.40M | $435.50M |
| Net Income from Continuing Operations | $202.80M | $216.30M | $736.80M | $143.50M | $182.20M |
| Gain/Loss from Continuing Operations | -$2.70M | -$2.30M | $50.60M | $57.20M | -$2.20M |
| Depreciation & Depletion & Amortization | $64.30M | $62.90M | $247.40M | $65.80M | $64.10M |
| Deferred Tax | -$100,000.00 | $4.50M | $36.00M | $4.30M | $44.50M |
| Other Non-Cash Items | $5.30M | -$200,000.00 | $12.30M | $6.70M | -$100,000.00 |
| Change in Working Capital | -$1.00M | -$134.00M | $9.80M | $73.80M | $122.10M |
| -Change in Receivables | -$19.60M | $13.70M | $39.40M | $21.90M | $13.20M |
| -Change in Inventory | -$20.30M | -$45.10M | $56.10M | $59.40M | -$400,000.00 |
| -Change in Payables and Accrued Expense | $43.30M | -$84.80M | -$63.60M | -$6.70M | $119.10M |
| -Change in Other Current Assets | -$3.80M | -$8.30M | $1.20M | -$500,000.00 | $2.60M |
| -Change In Other Working Capital | -$600,000.00 | -$9.50M | -$23.30M | -$300,000.00 | -$12.40M |
| Net cash flow from investing | -$328.40M | -$33.50M | -$616.90M | $108.40M | -$685.70M |
| Net Cash Flow from Continuing Investing Activities | -$328.40M | -$33.50M | -$616.90M | $108.40M | -$685.70M |
| Net PPE Purchase and Sale | -$29.90M | -$31.90M | -$122.40M | -$55.20M | -$28.20M |
| Net Other Investing Changes | $1.50M | -$1.60M | $1.20M | $2.90M | -$1.10M |
| Financing Cash Flow | -$206.80M | -$44.90M | -$1.16B | -$368.50M | -$367.10M |
| Net Cash Flow from Continuing Financing Activities | -$206.80M | -$44.90M | -$1.16B | -$368.50M | -$367.10M |
| Cash Dividends Paid | -$72.90M | -$72.90M | -$287.20M | -$70.80M | -$71.40M |
| Proceeds from Stock Option Exercised | $14.20M | $16.60M | $35.60M | $2.50M | $6.50M |
| Net Other Financing Charges | -$198.00M | $11.40M | -$10.80M | -$200,000.00 | -$2.20M |
| Ending Cash Balance | $254.80M | $503.40M | $409.00M | $409.00M | $305.30M |
| Net Change in Cash | -$248.40M | $96.40M | -$563.90M | $103.30M | -$617.30M |
| Beginning Cash Balance | $503.40M | $409.00M | $964.10M | $305.30M | $923.20M |
| Effect of Exchange Rate Changes | -$200,000.00 | -$2.00M | $8.80M | $400,000.00 | -$600,000.00 |
| Free Cash Flow | $256.90M | $142.90M | $1.09B | $308.20M | $407.30M |
| Net Business Purchase and Sale | – | – | -$495.70M | $160.70M | -$656.40M |
| Net Issuance Payments Of Debt | – | – | $0.00 | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | -$900.00M | -$300.00M | -$300.00M |
No comments yet — be the first to weigh in on CHD.